| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $1.53 ▲ +1.59% | Yesterday | $1.50 ▼ -0.67% | Tomorrow's Innate Pharma S.A. ADS (IPHA) setup is anchored to $1.51 and targets $1.53 (+1.59%). The near-term read is upside; watch $1.56 / $1.46 because daily realized volatility is about 8.00%. |
Tomorrow's Innate Pharma S.A. ADS (IPHA) setup is anchored to $1.51 and targets $1.53 (+1.59%). The near-term read is upside; watch $1.56 / $1.46 because daily realized volatility is about 8.00%. | ||||
| Week | $1.58 ▲ +4.95% | Last Week | $1.48 ▼ -2.08% | The 7-day Innate Pharma S.A. ADS model moves from $1.48 to $1.58 (+4.95%). It gives upside momentum context for this stock, so breaks around $1.56 / $1.46 matter more than a single tick. |
The 7-day Innate Pharma S.A. ADS model moves from $1.48 to $1.58 (+4.95%). It gives upside momentum context for this stock, so breaks around $1.56 / $1.46 matter more than a single tick. | ||||
| Month | $1.67 ▲ +10.54% | Last Month | $1.44 ▼ -4.43% | The 1-month Innate Pharma S.A. ADS target is $1.67 (+10.54%), compared with the live reference near $1.51. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Innate Pharma S.A. ADS target is $1.67 (+10.54%), compared with the live reference near $1.51. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $1.80 ▲ +18.93% | Last Year | $1.39 ▼ -7.95% | The 1-year Innate Pharma S.A. ADS scenario points to $1.80 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Innate Pharma S.A. ADS scenario points to $1.80 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $2.09 ▲ +38.57% | 5 Years Ago | $1.27 ▼ -16.20% | The 5-year Innate Pharma S.A. ADS view is $2.09 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Innate Pharma S.A. ADS view is $2.09 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $1.51 | Mid |
| Daily Change | -5.03% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 68% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $1.51 | Daily Change | -5.03% |
| Market Cap | $141.62M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.